Zoetis Inc (ZTS)
176.71
+1.04
(+0.59%)
USD |
NYSE |
Nov 21, 16:00
176.71
0.00 (0.00%)
Pre-Market: 20:00
Zoetis Total Assets (Quarterly): 14.36B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.36B |
| June 30, 2024 | 14.16B |
| March 31, 2024 | 14.35B |
| December 31, 2023 | 14.29B |
| September 30, 2023 | 14.11B |
| June 30, 2023 | 13.75B |
| March 31, 2023 | 13.75B |
| December 31, 2022 | 14.92B |
| September 30, 2022 | 13.67B |
| June 30, 2022 | 13.77B |
| March 31, 2022 | 13.86B |
| December 31, 2021 | 13.90B |
| September 30, 2021 | 13.70B |
| June 30, 2021 | 14.07B |
| March 31, 2021 | 13.80B |
| December 31, 2020 | 13.61B |
| September 30, 2020 | 13.72B |
| June 30, 2020 | 13.07B |
| March 31, 2020 | 11.53B |
| December 31, 2019 | 11.54B |
| September 30, 2019 | 11.27B |
| June 30, 2019 | 10.99B |
| March 31, 2019 | 10.88B |
| December 31, 2018 | 10.78B |
| September 30, 2018 | 10.46B |
| Date | Value |
|---|---|
| June 30, 2018 | 8.603B |
| March 31, 2018 | 8.69B |
| December 31, 2017 | 8.586B |
| September 30, 2017 | 9.288B |
| June 30, 2017 | 7.802B |
| March 31, 2017 | 7.649B |
| December 31, 2016 | 7.649B |
| September 30, 2016 | 7.715B |
| June 30, 2016 | 7.518B |
| March 31, 2016 | 7.453B |
| December 31, 2015 | 7.913B |
| September 30, 2015 | 6.686B |
| June 30, 2015 | 6.598B |
| March 31, 2015 | 6.43B |
| December 31, 2014 | 6.588B |
| September 30, 2014 | 6.527B |
| June 30, 2014 | 6.522B |
| March 31, 2014 | 6.403B |
| December 31, 2013 | 6.558B |
| September 30, 2013 | 6.259B |
| June 30, 2013 | 6.261B |
| March 31, 2013 | 6.142B |
| December 31, 2012 | 6.262B |
| September 30, 2012 | 5.904B |
| June 30, 2012 | 5.80B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.53B
Minimum
Mar 2020
14.92B
Maximum
Dec 2022
13.70B
Average
13.78B
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Vertex Pharmaceuticals Inc | 22.24B |
| Alnylam Pharmaceuticals Inc | 4.205B |
| Biomarin Pharmaceutical Inc | 6.851B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.123B |
| Shareholders Equity (Quarterly) | 5.234B |
| Debt to Equity Ratio | 1.256 |
| Current Ratio | 3.691 |
| Net Debt Paydown Yield | -0.00% |